Profile
Richard M.
Soll is currently the Director at the Children's Tumor Foundation and the SVP-International Discovery Service Unit at WuXi AppTec Co., Ltd. He previously served as the Director & Manager at Simcha Therapeutics Holding Co. LLC, Vice President-Chemistry at 3-Dimensional Pharmaceuticals, Inc., CSO and Vice President-Research & Development at TargeGen, Inc., and Vice President-Chemistry at Ontogen Corp.
Dr. Soll holds a doctorate degree from Dartmouth College and an undergraduate degree from the University of Massachusetts.
Richard M. Soll active positions
| Companies | Position | Start |
|---|---|---|
| WUXI APPTEC CO., LTD. | Corporate Officer/Principal | - |
Children's Tumor Foundation
Children's Tumor Foundation Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Director/Board Member | - |
Former positions of Richard M. Soll
| Companies | Position | End |
|---|---|---|
TargeGen, Inc.
TargeGen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures vascular biopharmaceutical products | Chief Tech/Sci/R&D Officer | 01/03/2008 |
Ontogen Corp. | Corporate Officer/Principal | 01/03/2003 |
3-Dimensional Pharmaceuticals, Inc.
3-Dimensional Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products and discovers drug candidates using its accelerated methodology for small molecule drug discovery | Corporate Officer/Principal | 01/03/2002 |
Simcha Therapeutics Holding Co. LLC
Simcha Therapeutics Holding Co. LLC BiotechnologyHealth Technology Operates as a biotechnology company | Director/Board Member | - |
Training of Richard M. Soll
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
3-Dimensional Pharmaceuticals, Inc.
3-Dimensional Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products and discovers drug candidates using its accelerated methodology for small molecule drug discovery | Health Technology |
TargeGen, Inc.
TargeGen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures vascular biopharmaceutical products | Health Technology |
Dartmouth College
Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Massachusetts
University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Children's Tumor Foundation
Children's Tumor Foundation Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures biopharmaceutical products & medical devices | Health Technology |
Ontogen Corp. | |
Simcha Therapeutics Holding Co. LLC
Simcha Therapeutics Holding Co. LLC BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
- Stock Market
- Insiders
- Richard M. Soll
















